TALK Quote, Financials, Valuation and Earnings

Lifestance Health Group, Inc. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of 0.3%. Talkspace, Inc.'s return on equity of 3.72% beat Lifestance Health Group, Inc.'s return on equity of -0.62%.

Talkspace, Inc. has a consensus price target of $5.08, signalling upside risk potential of 60.36%. On the other hand Lifestance Health Group, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 31.58%. Given that Talkspace, Inc. has higher upside potential than Lifestance Health Group, Inc., analysts believe Talkspace, Inc. is more attractive than Lifestance Health Group, Inc..

Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison Lifestance Health Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifestance Health Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Lifestance Health Group, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $59.4M, which are smaller than Lifestance Health Group, Inc. quarterly revenues of $363.8M. Talkspace, Inc.'s net income of $3.3M is higher than Lifestance Health Group, Inc.'s net income of $1.1M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 129.39x while Lifestance Health Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.55x versus 1.83x for Lifestance Health Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Marpai, Inc. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of -86.55%. Talkspace, Inc.'s return on equity of 3.72% beat Marpai, Inc.'s return on equity of --.

Talkspace, Inc. has a consensus price target of $5.08, signalling upside risk potential of 60.36%. On the other hand Marpai, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Talkspace, Inc. has higher upside potential than Marpai, Inc., analysts believe Talkspace, Inc. is more attractive than Marpai, Inc..

Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison Marpai, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marpai, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Marpai, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $59.4M, which are larger than Marpai, Inc. quarterly revenues of $4M. Talkspace, Inc.'s net income of $3.3M is higher than Marpai, Inc.'s net income of -$3.5M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 129.39x while Marpai, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.55x versus 0.58x for Marpai, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Teladoc Health, Inc. has a net margin of 5.48% compared to Talkspace, Inc.'s net margin of -7.9%. Talkspace, Inc.'s return on equity of 3.72% beat Teladoc Health, Inc.'s return on equity of -15.44%.

Talkspace, Inc. has a consensus price target of $5.08, signalling upside risk potential of 60.36%. On the other hand Teladoc Health, Inc. has an analysts' consensus of $9.21 which suggests that it could grow by 18.37%. Given that Talkspace, Inc. has higher upside potential than Teladoc Health, Inc., analysts believe Talkspace, Inc. is more attractive than Teladoc Health, Inc..

Talkspace, Inc. has a beta of 1.206, which suggesting that the stock is 20.567% more volatile than S&P 500. In comparison Teladoc Health, Inc. has a beta of 2.036, suggesting its more volatile than the S&P 500 by 103.638%.

Talkspace, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teladoc Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Talkspace, Inc. pays -- of its earnings as a dividend. Teladoc Health, Inc. pays out -- of its earnings as a dividend.

Talkspace, Inc. quarterly revenues are $59.4M, which are smaller than Teladoc Health, Inc. quarterly revenues of $626.4M. Talkspace, Inc.'s net income of $3.3M is higher than Teladoc Health, Inc.'s net income of -$49.5M. Notably, Talkspace, Inc.'s price-to-earnings ratio is 129.39x while Teladoc Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Talkspace, Inc. is 2.55x versus 0.54x for Teladoc Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.